BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2003 to 2024. Read More.

Open Access Percentage

67%

Total
Publications

120

Total Open
Publications

Total
Citations

4.6K

Open Access
Percentage

67%

Total
Publications

120

Total Open
Publications

Total
Citations

4.6K

Wikipedia

Website

download

Breakdown

Publisher Open

26%

Both

25%

Other Platform Open

Closed

43%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 38%

Hybrid 35%

No Guarantees 27%

Other Platform Open

Domain 72%

Other Internet 19%

Preprint 9%

Public 3%

Institution 0%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	23
DOI	Other Internet	6
Research Square	Preprint	3
Figshare	Public	1

1 / 1

Data updated 18 August 2025